Artal Group S.A. Senti Biosciences, Inc. Transaction History

Artal Group S.A.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 13, 2023	SELL	$1.25 - $65.2 $1.25 Million - $65.2 Million	-1,000,000 Reduced 94.74%	55,555 $78,000
Q2 2022 Aug 11, 2022	BUY	$1.97 - $10.0 $2.08 Million - $10.6 Million	1,055,555 New	1,055,555 $2.07 Million

8.79M

Ticker SNTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,757,100
Market Cap $95.8M
Description
Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.